In vivo creatine kinase reaction kinetics at rest and stress in type II diabetic rat heart

Physiological Reports

Volumn 3, Issue 1, 2015, Pages

  Bashir, Adil ^a   Coggan, Andrew R ^a   Gropler, Robert J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

31P; Creatine kinase flux; Diabetic cardiomyopathy; Heart; Type II diabetes

Indexed keywords

ADENOSINE TRIPHOSPHATE; CREATINE KINASE MB; CREATINE PHOSPHATE; DOBUTAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHEMICAL REACTION KINETICS; CONTROLLED STUDY; DIABETIC OBESITY; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEART RATE; HYPERGLYCEMIA; IN VIVO STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PHYSIOLOGICAL STRESS; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; ZUCKER DIABETIC FATTY RAT;

EID: 85006826464     PISSN: None     EISSN: 2051817X     Source Type: Journal    
DOI: 10.14814/phy2.12248     Document Type: Article

References (54)

1. Alger, J. R., and R. G. Shulman. 1984. NMR studies of enzymatic rates in vitro and in vivo by magnetization transfer. Q. Rev. Biophys. 17:83-124.
2. Awaji, Y., H. Hashimoto, Y. Matsui, K. Kawaguchi, K. Okumura, T. Ito, et al. 1990. Isoenzyme profiles of creatine kinase, lactate dehydrogenase, and aspartate aminotransferase in the diabetic heart: comparison with hereditary and catecholamine cardiomyopathies. Cardiovasc. Res. 24:547-554.
3. Bashir, A., and R. Gropler. 2014. Reproducibility of creatine kinase reaction kinetics in human heart: a (31) P time-dependent saturation transfer spectroscopy study. NMR Biomed. 27:663-671.
4. Beer, M., T. Seyfarth, J. Sandstede, W. Landschutz, C. Lipke, H. Kostler, et al. 2002. Absolute concentrations of high-energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured noninvasively with (31)P-SLOOP magnetic resonance spectroscopy. J. Am. Coll. Cardiol. 40:1267-1274.
5. Bell, D. S. 2003. Diabetic cardiomyopathy. Diabetes Care 26:2949-2951.
6. Bittl, J. A., and J. S. Ingwall. 1985. Reaction rates of creatine kinase and ATP synthesis in the isolated rat heart. A 31P NMR magnetization transfer study. J. Biol. Chem. 260:3512-3517.
7. Boudina, S., S. Sena, B. T. O’Neill, P. Tathireddy, M. E. Young, and E. D. Abel. 2005. Reduced mitochondrial oxidative capacity and increased mitochondrial uncoupling impair myocardial energetics in obesity. Circulation 112:2686-2695.
8. van den Brom, C. E., J. W. Bosmans, R. Vlasblom, L. M. Handoko, M. C. Huisman, M. Lubberink, et al. 2010. Diabetic cardiomyopathy in Zucker diabetic fatty rats: the forgotten right ventricle. Cardiovasc. Diabetol. 9:25.
9. Chen, G., F. A. McAlister, R. L. Walker, B. R. Hemmelgarn, and N. R. Campbell. 2011. Cardiovascular outcomes in framingham participants with diabetes: the importance of blood pressure. Hypertension 57:891-897.
10. Cosson, S., and J. P. Kevorkian. 2003. Left ventricular diastolic dysfunction: an early sign of diabetic cardiomyopathy? Diabetes Metabol. 29:455-466.
11. Daniels, A., D. Linz, M. van Bilsen, H. Rutten, T. Sadowski, S. Ruf, et al. 2012. Long-term severe diabetes only leads to mild cardiac diastolic dysfunction in Zucker diabetic fatty rats. Eur. J. Heart Fail. 14:193-201.
12. Diamant, M., H. J. Lamb, Y. Groeneveld, E. L. Endert, J. W. Smit, J. J. Bax, et al. 2003. Diastolic dysfunction is associated with altered myocardial metabolism in asymptomatic normotensive patients with well-controlled type 2 diabetes mellitus. J. Am. Coll. Cardiol. 42:328-335.
13. Elliott, A. C., G. L. Smith, and D. G. Allen. 1994. The metabolic consequences of an increase in the frequency of stimulation in isolated ferret hearts. J. Physiol. 474:147-159.
14. El-Sharkawy, A. M., R. E. Gabr, M. Schar, R. G. Weiss, and P. A. Bottomley. 2013. Quantification of human high-energy phosphate metabolite concentrations at 3 T with partial volume and sensitivity corrections. NMR Biomed. 26: 1363-1371.
15. Fang, Z. Y., J. B. Prins, and T. H. Marwick. 2004. Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocr. Rev. 25:543-567.
16. Fontanet, H. L., R. V. Trask, R. C. Haas, A. W. Strauss, D. R. Abendschein, and J. J. Billadello. 1991. Regulation of expression of M, B, and mitochondrial creatine kinase mRNAs in the left ventricle after pressure overload in rats. Circ. Res. 68:1007-1012.
17. Fredersdorf, S., C. Thumann, C. Ulucan, D. P. Griese, A. Luchner, G. A. Riegger, et al. 2004. Myocardial hypertrophy and enhanced left ventricular contractility in Zucker diabetic fatty rats. Cardiovasc. Pathol. 13:11-19.
18. Gupta, A., V. P. Chacko, M. Schar, A. Akki, and R. G. Weiss. 2011. Impaired ATP kinetics in failing in vivo mouse heart. Circ. Cardiovasc. Imaging 4:42-50.
19. Haffner, S. M., S. Lehto, T. Ronnemaa, K. Pyorala, and M. Laakso. 1998. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N. Engl. J. Med. 339:229-234.
20. He, M. X., S. Wang, and H. F. Downey. 1997. Correlation between myocardial contractile force and cytosolic inorganic phosphate during early ischemia. Am. J. Physiol. 272: H1333-H1341.
21. Hitchins, S., J. M. Cieslar, and G. P. Dobson. 2001. 31P NMR quantitation of phosphorus metabolites in rat heart and skeletal muscle in vivo. Am. J. Physiol. Heart Circ. Physiol. 281:H882-H887.
22. Ingwall, J. S. 2002. Is creatine kinase a target for AMP-activated protein kinase in the heart? J. Mol. Cell. Cardiol. 34:1111-1120.
23. Ingwall, J. S. 2009. Energy metabolism in heart failure and remodelling. Cardiovasc. Res. 81:412-419.
24. Jilkina, O., B. Kuzio, and V. V. Kupriyanov. 2008. Potassium fluxes, energy metabolism, and oxygenation in intact diabetic rat hearts under normal and stress conditions. Can. J. Physiol. Pharmacol. 86:710-725.
25. Kemp, G. J., M. Meyerspeer, and E. Moser. 2007. Absolute quantification of phosphorus metabolite concentrations in human muscle in vivo by 31P MRS: a quantitative review. NMR Biomed. 20:555-565.
26. Khuchua, Z. A., R. Ventura-Clapier, A. V. Kuznetsov, M. N. Grishin, and V. A. Saks. 1989. Alterations in the creatine kinase system in the myocardium of cardiomyopathic hamsters. Biochem. Biophys. Res. Commun. 165:748-757.
27. Kuchel, P. W. 1990. Spin-exchange NMR spectroscopy in studies of the kinetics of enzymes and membrane transport. NMR Biomed. 3:102-119.
28. Kuo, T. H., K. H. Moore, F. Giacomelli, and J. Wiener. 1983. Defective oxidative metabolism of heart mitochondria from genetically diabetic mice. Diabetes 32:781-787.
29. Kuo, T. H., F. Giacomelli, and J. Wiener. 1985. Oxidative metabolism of Polytron versus Nagarse mitochondria in hearts of genetically diabetic mice. Biochim. Biophys. Acta 806:9-15.
30. Lin, G., Y. Liu, and K. M. MacLeod. 2009. Regulation of muscle creatine kinase by phosphorylation in normal and diabetic hearts. Cell. Mol. Life Sci. 66:135-144.
31. Lipskaya, T. Y. 2001. Mitochondrial creatine kinase: properties and function. Biochemistry (Mosc) 66:1098-1111.
32. Maslov, M. Y., V. P. Chacko, G. A. Hirsch, A. Akki, M. K. Leppo, C. Steenbergen, et al. 2010. Reduced in vivo high-energy phosphates precede adriamycin-induced cardiac dysfunction. Am. J. Physiol. Heart Circ. Physiol. 299: H332-H337.
33. Matsumoto, Y., M. Kaneko, A. Kobayashi, Y. Fujise, and N. Yamazaki. 1995. Creatine kinase kinetics in diabetic cardiomyopathy. Am. J. Physiol. 268:E1070-E1076.
34. Meerson, F. Z., and M. P. Javich. 1982. Isoenzyme pattern and activity of myocardial creatine phosphokinase under heart adaptation to prolonged overload. Basic Res. Cardiol. 77:349-358.
35. Metzler, B., M. F. Schocke, P. Steinboeck, C. Wolf, W. Judmaier, M. Lechleitner, et al. 2002. Decreased high-energy phosphate ratios in the myocardium of men with diabetes mellitus type I. J. Cardiovasc. Magn. Reson. 4:493-502.
36. Miki, T., S. Yuda, H. Kouzu, and T. Miura. 2013. Diabetic cardiomyopathy: pathophysiology and clinical features. Heart Fail. Rev. 18:149-166.
37. Naressi, A., C. Couturier, J. M. Devos, M. Janssen, C. Mangeat, R. de Beer, et al. 2001. Java-based graphical user interface for the MRUI quantitation package. MAGMA 12:141-152.
38. Nascimben, L., J. S. Ingwall, P. Pauletto, J. Friedrich, J. K. Gwathmey, V. Saks, et al. 1996. Creatine kinase system in failing and nonfailing human myocardium. Circulation 94:1894-1901.
39. Neubauer, S. 1999. High-energy phosphate metabolism in normal, hypertrophied and failing human myocardium. Heart Fail. Rev. 4:269-280.
40. Pauletto, P., L. Nascimben, D. Piccolo, S. Secchiero, G. Vescovo, G. Scannapieco, et al. 1989. Ventricular myosin and creatine-kinase isoenzymes in hypertensive rats treated with captopril. Hypertension 14:556-562.
41. Popovich, B. K., K. R. Boheler, and W. H. Dillmann. 1989. Diabetes decreases creatine kinase enzyme activity and mRNA level in the rat heart. Am. J. Physiol. 257:E573-E577.
42. Savabi, F. 1988. Mitochondrial creatine phosphokinase deficiency in diabetic rat heart. Biochem. Biophys. Res. Commun. 154:469-475.
43. Savabi, F., and A. Kirsch. 1991. Alteration of the phosphocreatine energy shuttle components in diabetic rat heart. J. Mol. Cell. Cardiol. 23:1323-1333.
44. Scheuermann-Freestone, M., P. L. Madsen, D. Manners, A. M. Blamire, R. E. Buckingham, P. Styles, et al. 2003. Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes. Circulation 107:3040-3046.
45. Somjen, D., M. Shen, N. Stern, and N. Mirsky. 2006. Diabetes modulates differentially creatine kinase-specific activity responsiveness to estradiol-17beta and to raloxifene in rat organs. J. Cell. Biochem. 99:133-139.
46. Spindler, M., K. W. Saupe, R. Tian, S. Ahmed, M. A. Matlib, and J. S. Ingwall. 1999. Altered creatine kinase enzyme kinetics in diabetic cardiomyopathy. A(31)P NMR magnetization transfer study of the intact beating rat heart. J. Mol. Cell. Cardiol. 31:2175-2189.
47. Stroedter, D., T. Schmidt, R. G. Bretzel, and K. Federlin. 1995. Glucose metabolism and left ventricular dysfunction are normalized by insulin and islet transplantation in mild diabetes in the rat. Acta Diabetol. 32:235-243.
48. Taegtmeyer, H., P. McNulty, and M. E. Young. 2002. Adaptation and maladaptation of the heart in diabetes: part I: general concepts. Circulation 105:1727-1733.
49. Vanhamme, L., A. van den Boogaart, and S. Van Huffel. 1997. Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. J. Magn. Reson. 129:35-43.
50. Vatner, D. E., and J. S. Ingwall. 1984. Effects of moderate pressure overload cardiac hypertrophy on the distribution of creatine kinase isozymes. Proc. Soc. Exp. Biol. Med. 175:5-9.
51. Voulgari, C., D. Papadogiannis, and N. Tentolouris. 2010. Diabetic cardiomyopathy: from the pathophysiology of the cardiac myocytes to current diagnosis and management strategies. Vasc. Health Risk Manag. 6:883-903.
52. Wallimann, T., M. Tokarska-Schlattner, and U. Schlattner. 2011. The creatine kinase system and pleiotropic effects of creatine. Amino Acids 40:1271-1296.
53. Younes, A., J. M. Schneider, J. Bercovici, and B. Swynghedauw. 1985. Redistribution of creatine kinase isoenzymes in chronically overloaded myocardium. Cardiovasc. Res. 19:15-19.
54. Young, M. E., P. McNulty, and H. Taegtmeyer. 2002. Adaptation and maladaptation of the heart in diabetes: part II: potential mechanisms. Circulation 105:1861-1870.